Vermillion Wealth Management’s Globus Medical GMED Stock Holding History

Vermillion Wealth Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7	Closed	-$603	–	1901
2026 Q1	$603	Buy	+7	New	+$628	﹤0.01%	951

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vermillion Wealth Management's GMED Position: Q2 2026 in Review

Vermillion Wealth Management sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 7 shares — an estimated $603 sold.

Vermillion Wealth Management first reported a position in GMED in Q1 2026 and held it in 1 quarter. The position peaked at $603 in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Vermillion Wealth Management reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Vermillion Wealth Management sold 7 Globus Medical shares in Q2 2026, an estimated $603.
Vermillion Wealth Management first reported a position in Globus Medical in Q1 2026 and held it in 1 quarter.
Vermillion Wealth Management's Globus Medical position peaked at $603 in Q1 2026.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.